ABL Diagnostics (XPAR:ABLD) Forward Dividend Yield %: 4.14% (As of Jul. 06, 2026)


XPAR:ABLD ABL Diagnostics XPAR:ABLD
51 GF Score
Price €2.66
GF Value €7.71
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is ABL Diagnostics Forward Dividend Yield %?

ABL Diagnostics XPAR:ABLD +0.76% 51 Forward Dividend Yield % is 4.14% as of Jul. 06, 2026. GuruFocus rates XPAR:ABLD with a GF Score™ of 51/100 and a GF Value™ of €7.71 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 274 Healthcare Providers & Services companies, ABL Diagnostics ranks better than 76.28% on this metric.

As of today (2026-07-06), the Forward Annual Dividend Yield of ABL Diagnostics is 4.14%.

As of today (2026-07-06), the Trailing Annual Dividend Yield of ABL Diagnostics is 4.14%.

XPAR:ABLD's Forward Dividend Yield % is ranked better than
76.28% of 274 companies
in the Healthcare Providers & Services industry
Industry Median: 2.51 vs XPAR:ABLD: 4.14

ABL Diagnostics's Dividends per Share for the six months ended in Dec. 2025 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


ABL Diagnostics  (XPAR:ABLD) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


ABL Diagnostics Forward Dividend Yield % Related Terms


XPAR:ABLD vs VEEV, BTSG, TEM: Forward Dividend Yield % Comparison

For the Health Information Services subindustry, ABL Diagnostics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ABL Diagnostics Forward Dividend Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where ABL Diagnostics's Forward Dividend Yield % falls into.


XPAR:ABLD
51GF Score
ABL Diagnostics XPAR:ABLD
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ABL Diagnostics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

ABL Diagnostics Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
EUR 0.1100002026-07-032026-07-062026-07-07Cash DividendannuallyEUR:EUR 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

ABL Diagnostics's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.11/2.66
=4.14 %

Current Share Price is €2.66.
ABL Diagnostics's Dividends per Share for the forward twelve months is calculated as €0.11 * 1 = €0.11.

ABL Diagnostics's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.11/2.66
=4.14 %

Current Share Price is €2.66.
ABL Diagnostics's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.11.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 4.14% mean?
ABL Diagnostics (XPAR:ABLD) has a Forward Dividend Yield % of 4.14% as of Jul. 06, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on ABL Diagnostics and its competitors. According to the industry distribution chart, ABL Diagnostics ranks #65 out of 274 companies in the Healthcare Providers & Services industry, placing it in the top 23.7%.
Is ABL Diagnostics' Forward Dividend Yield % too high?
ABL Diagnostics' current Forward Dividend Yield % is 4.14%. The Healthcare Providers & Services industry median Forward Dividend Yield % is 2.51. ABL Diagnostics' value of 4.14% is 64.9% above this industry median. Based on the distribution chart, ABL Diagnostics ranks #65 out of 274 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, ABL Diagnostics has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ABL Diagnostics' Forward Dividend Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, ABL Diagnostics ranks #65 out of 274 companies for Forward Dividend Yield %. This places ABL Diagnostics in the top 24% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 2.51. ABL Diagnostics' value of 4.14% is 64.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.51, based on 274 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ABL Diagnostics's current Forward Dividend Yield % of 4.14% is 64.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on ABL Diagnostics and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ABL Diagnostics's current Forward Dividend Yield % is 4.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABL Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, ABL Diagnostics (XPAR:ABLD) is currently considered Significantly Undervalued. The stock's GF Value™ is €7.71, compared to a current price of €2.66 — trading 65.5% below its estimated fair value. The current Forward Dividend Yield % is 4.14% and 64.9% above the Healthcare Providers & Services industry median of 2.51. ABL Diagnostics' overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For ABL Diagnostics (XPAR:ABLD), the current Forward Dividend Yield % is 4.14% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ABL Diagnostics (XPAR:ABLD) Overvalued in 2026?

Based on GuruFocus' analysis, ABL Diagnostics stock appears to be undervalued. The current stock price of €2.66 is trading 65.5% below its estimated GF Value™ of €7.71. GuruFocus considers ABL Diagnostics to be Significantly Undervalued.

Key valuation signals for XPAR:ABLD:

  • Forward Dividend Yield %: 4.14%
  • GF Value™: €7.71 vs. price of €2.66 (65.5% below fair value)
  • GF Score™: 51/100 with 4 warning signs
  • Industry Position: 64.9% above the Healthcare Providers & Services median (#65 of 274)

No single metric tells the full story. See the XPAR:ABLD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ABL Diagnostics Business Description

Other Exchanges 9BK0:Germany
Address 72c, rue de, WOIPPY, Thionville, FRA, 57140
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.
51GF Score

Get the complete analysis for XPAR:ABLD

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.66
Price
€7.71
GF Value